Radiomics in Oncological PET/CT: Clinical Applications / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
;
: 170-189, 2018.
Article
in English
| WPRIM
| ID: wpr-997387
ABSTRACT
¹â¸F–fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely used for staging, evaluating treatment response, and predicting prognosis in malignant diseases. FDG uptake and volumetric PET parameters such as metabolic tumor volume have been used and are still used as conventional PET parameters to assess biological characteristics of tumors. However, in recent years, additional features derived from PET images by computational processing have been found to reflect intratumoral heterogeneity, which is related to biological tumor features, and to provide additional predictive and prognostic information, which leads to the concept of radiomics. In this review, we focus on recent clinical studies of malignant diseases that investigated intratumoral heterogeneity on PET/CT, and we discuss its clinical role in various cancers.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Korean Journal of Nuclear Medicine
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS